chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Serum ferritin normal, Sputum culture, Transfusion, Unresponsive to stimuli
Clinical narrative: 12/9/21:  Patient admitted post fall and left sided weakness.  Found to have left cerebellar infarct and left intertrochanteric femur fracture.  Covid negative on admission and no symptoms. 12/10/21:  OR for nailing of femur fracture 12/11/21:  developed aphasia and aspiration PNA 12/13-12/17:  in and out of afib with RVR treated with IV Cardizem.  Continues to have no Covid symptoms.  NPO due to aspiration risk.  For PEG tube.  Improving lung imaging post IV abx for aspiration PNA.  On 2L via NC sat >97%. 12/22/21:  Symptomatic bradycardia events.  Need for pacemacker 12/24/21:  GI bleed with transfusion needed.  Continues to have no Covid symptoms.  2L NC sat >95%.  Ferritin 235 WBC 20.8 12/27/21:  Continued leukocytosis WBC 18.2, GFR 34.  Increased resp. rate 26-32, increased oxygen need 4L NC to sat >92%.  Temp 98.6 F.  Tested Covid positive and concerns for aspiration.  CXR shows increased pulmonary infiltrates bilaterally with small left pleural effusion.  Started IV Remdesivir, decadron, flagyl, cefepime, and vitamin cocktail. 12/28/21:  Concern for PE, unable to do VQ scan due to AKI and allergies.  Started on heparin gtt.  GFR 30, temp 99.5 F, AST 39 ALT 32.  Remdesivir stopped.  Started on renal dose baricitinib.  RR 30-32 sat >92% on 5L NC. 12/29/21: @0540 patient becoming unresponsive with desaturation.  On NRBM sat 80% RR varied from 12 to 40.  Rapid response called.  ABG on NRBM 6.992 CO2 >100 unobtainable BE or HCO3.  Rhonchi and rales throughout bilateral lungs with weak inspiratory effort in acute hypercapnic/hypoxic respiratory failure.  Patient intubated and placed on Bilevel 28/20 PS 20 FiO2 100%.  CXR shows increased bilateral atelectasis and infiltrates.  GFR 29 Temp 100.0F. BP 82/41 started on Levophed.  Two hour post intubation ABG 7.298/54.6/236/26.7/-0.2. 12/30/21:  Off Levophed and sedation, minimal response to painful stimuli.  Afebrile, breathing only with vent, Bilevel 28/8 PS 20 RR 18 FiO2 45% sat 97%.  WBC 13.4, Ferritin 108, GFR 23, Ddimer 2576, AST 71, ALT 50. 12/31/21:   GFR 18 continues to be minimal nonpurposeful movement to painful stimuli off sedation.  Sputum cx negative.  End of life family meeting decide to make comfort care.  @2020 terminal extubation with rapid decline and expiration.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: 12/9/21:  Patient admitted post fall and left sided weakness.  Found to have left cerebellar infarct and left intertrochanteric femur fracture.  Covid negative on admission and no symptoms. 12/10/21:  OR for nailing of femur fracture 12/11/21:  developed aphasia and aspiration PNA 12/13-12/17:  in and out of afib with RVR treated with IV Cardizem.  Continues to have no Covid symptoms.  NPO due to aspiration risk.  For PEG tube.  Improving lung imaging post IV abx for aspiration PNA.  On 2L via NC sat >97%. 12/22/21:  Symptomatic bradycardia events.  Need for pacemacker 12/24/21:  GI bleed with transfusion needed.  Continues to have no Covid symptoms.  2L NC sat >95%.  Ferritin 235 WBC 20.8 12/27/21:  Continued leukocytosis WBC 18.2, GFR 34.  Increased resp. rate 26-32, increased oxygen need 4L NC to sat >92%.  Temp 98.6 F.  Tested Covid positive and concerns for aspiration.  CXR shows increased pulmonary infiltrates bilaterally with small left pleural effusion.  Started IV Remdesivir, decadron, flagyl, cefepime, and vitamin cocktail. 12/28/21:  Concern for PE, unable to do VQ scan due to AKI and allergies.  Started on heparin gtt.  GFR 30, temp 99.5 F, AST 39 ALT 32.  Remdesivir stopped.  Started on renal dose baricitinib.  RR 30-32 sat >92% on 5L NC. 12/29/21: @0540 patient becoming unresponsive with desaturation.  On NRBM sat 80% RR varied from 12 to 40.  Rapid response called.  ABG on NRBM 6.992 CO2 >100 unobtainable BE or HCO3.  Rhonchi and rales throughout bilateral lungs with weak inspiratory effort in acute hypercapnic/hypoxic respiratory failure.  Patient intubated and placed on Bilevel 28/20 PS 20 FiO2 100%.  CXR shows increased bilateral atelectasis and infiltrates.  GFR 29 Temp 100.0F. BP 82/41 started on Levophed.  Two hour post intubation ABG 7.298/54.6/236/26.7/-0.2. 12/30/21:  Off Levophed and sedation, minimal response to painful stimuli.  Afebrile, breathing only with vent, Bilevel 28/8 PS 20 RR 18 FiO2 45% sat 97%.  WBC 13.4, Ferritin 108, GFR 23, Ddimer 2576, AST 71, ALT 50. 12/31/21:   GFR 18 continues to be minimal nonpurposeful movement to painful stimuli off sedation.  Sputum cx negative.  End of life family meeting decide to make comfort care.  @2020 terminal extubation with rapid decline and expiration.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Colitis, Computerised tomogram abnormal, Diarrhoea, Nausea
Clinical narrative: Abdominal pain with hx of NASH cirrhosis. CT shows no ascites, positive for colitis. Pt having diarrhea and nausea. Pt admitted for IV antibiotics for acute colitis. Monitor labs for NASH cirrhosis, CKD and DM.
Age: 11.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient's age was 11 years and 9 months at the time of first injection. Second injection patient was 11 years and 10 months of age.  Guardian had denoted on paperwork that patient was 12 years old at the time of both injections.
Age: 39.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Magnetic resonance imaging abnormal, Pain, Paraesthesia, Sensory disturbance
Clinical narrative: ON 1/12/2022 AT ABOUT 2:55 PM I RECEIVED A FLU SHOT (Flu Shot Quadrivalent Manufacturer: Sanofi Pasteur) ON MY RIGHT ARM. IT SEEMS THAT THE VACCINE WAS ADMINISTERED INCORRECTLY. I HAD AN MRI DONE ON 2/03/2022 AND ON 2/4/2022 THE MRI RESULTS WERE READ AND IT WAS DETERMINED THAT THE NEEDLE HAD CAUSED THE ISSUE WITH MY ARM. I HAVE PAIN IN MY RIGHT SHOULDER WHEN I ROTATE MY ARM. LIFTING MY ARM OVER MY HEAD CAUSES PAIN. AND MY ARM HAS BEEN FALLING ASLEEP EVEN THOUGH IM NOT LAYING ON IT. I ALSO GET A THROBBING AND PINCHING FEELING ALL THE WAY AT THE TOP OF MY ARM. IT HAS BEEN 4 WEEKS AND THERE IS NO RELIEF. I AM SCHEDULED FOR PHYSICAL THERAPY NEXT WEEK.
Age: 39.0
Sex: F
Vaccine: FLU4
Symptoms: Wrong technique in product usage process
Clinical narrative: ON 1/12/2022 AT ABOUT 2:55 PM I RECEIVED A FLU SHOT (Flu Shot Quadrivalent Manufacturer: Sanofi Pasteur) ON MY RIGHT ARM. IT SEEMS THAT THE VACCINE WAS ADMINISTERED INCORRECTLY. I HAD AN MRI DONE ON 2/03/2022 AND ON 2/4/2022 THE MRI RESULTS WERE READ AND IT WAS DETERMINED THAT THE NEEDLE HAD CAUSED THE ISSUE WITH MY ARM. I HAVE PAIN IN MY RIGHT SHOULDER WHEN I ROTATE MY ARM. LIFTING MY ARM OVER MY HEAD CAUSES PAIN. AND MY ARM HAS BEEN FALLING ASLEEP EVEN THOUGH IM NOT LAYING ON IT. I ALSO GET A THROBBING AND PINCHING FEELING ALL THE WAY AT THE TOP OF MY ARM. IT HAS BEEN 4 WEEKS AND THERE IS NO RELIEF. I AM SCHEDULED FOR PHYSICAL THERAPY NEXT WEEK.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Rash, Urticaria
Clinical narrative: Began having rashes/hives on my upper left chest.  This has continued and now also happens on my left side, back, left chest, left leg, and scalp.  We have treated with topical and oral steroids and have not found any other cause for this and it is all left sided body which would eliminate it being soap/detergent related.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 3rd vaccine; breakthrough case.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram, Cerebrovascular accident, Computerised tomogram, Death, Magnetic resonance imaging
Clinical narrative: Acute ischemic CVA involving left cerebellum, brainstem, thalamus, and left posterior circulation eventually leading to multiorgan failure and death
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Multiple organ dysfunction syndrome
Clinical narrative: Acute ischemic CVA involving left cerebellum, brainstem, thalamus, and left posterior circulation eventually leading to multiorgan failure and death
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris, Condition aggravated
Clinical narrative: Heart pain since a couple of weeks after the injection
Age: 56.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19
Age: 95.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 2nd vaccine; breakthrough case
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Herpes zoster, Rash vesicular
Clinical narrative: Severe Headache with blister rash on left side of face, head, neck, and shoulder area.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site cellulitis, Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Pt received vaccine at outside clinic (mobile clinic) on 2/6/22.  This is her 3rd Moderna vaccine.  The night of 2/6 she developed pain/redness in left deltoid.  Pain improved but redness & swelling has worsened.  Lesion size: 7cm x 5.5 cm.  Hot, warm and tender.  Given Keflex 500mg TID x 5 days for cellulitis reaction.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Skin lesion
Clinical narrative: Pt received vaccine at outside clinic (mobile clinic) on 2/6/22.  This is her 3rd Moderna vaccine.  The night of 2/6 she developed pain/redness in left deltoid.  Pain improved but redness & swelling has worsened.  Lesion size: 7cm x 5.5 cm.  Hot, warm and tender.  Given Keflex 500mg TID x 5 days for cellulitis reaction.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive for COVID-19.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 3rd vaccine; breakthrough case
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Hypomenorrhoea
Clinical narrative: On Jan 28, the day after shot, I experienced light menstrual bleeding. It went on for 4 days.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 2nd vaccine; breakthrough case
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19, COVID-19 pneumonia, Diarrhoea, Nausea
Clinical narrative: Hospitalized on 2/7 emesis started 2/6 pt with and acute kidney injury and COVID 19  + home antigen test on 2/1/2022. Nausea, vomiting and diarrhea related to COVID 19 pneumonia. Remdesivir 200 mg IV day one than 100 mg IV day 2 and day 3.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting
Clinical narrative: Hospitalized on 2/7 emesis started 2/6 pt with and acute kidney injury and COVID 19  + home antigen test on 2/1/2022. Nausea, vomiting and diarrhea related to COVID 19 pneumonia. Remdesivir 200 mg IV day one than 100 mg IV day 2 and day 3.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Antinuclear antibody negative, Contusion, Cytomegalovirus test negative, Decreased appetite, Erythema
Clinical narrative: Within one week of receiving the first Pfizer vaccine patient had about 10 papular, red, mildly pruritic lesions on the arms which resolved.   Within 1-2 weeks after the second vaccine the same lesions on arms, chest, legs appeared in abundance.  More importantly she developed nausea, anorexia, fatigue, weight loss and extensive bruising on the entirety of both legs.  Liver issues were suspected and full set of blood work revealed ELEVATED TRANSAMINASES to the mid 300s.  All other labs including CBC, hepatitis titers, CMV, ANA were all negative as was an ultrasound.  Patient stopped the supplements and slowly resolved over the next month
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Full blood count normal, Hepatitis viral test negative, Laboratory test normal, Liver disorder
Clinical narrative: Within one week of receiving the first Pfizer vaccine patient had about 10 papular, red, mildly pruritic lesions on the arms which resolved.   Within 1-2 weeks after the second vaccine the same lesions on arms, chest, legs appeared in abundance.  More importantly she developed nausea, anorexia, fatigue, weight loss and extensive bruising on the entirety of both legs.  Liver issues were suspected and full set of blood work revealed ELEVATED TRANSAMINASES to the mid 300s.  All other labs including CBC, hepatitis titers, CMV, ANA were all negative as was an ultrasound.  Patient stopped the supplements and slowly resolved over the next month
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Papule, Pruritus, Skin lesion, Transaminases increased
Clinical narrative: Within one week of receiving the first Pfizer vaccine patient had about 10 papular, red, mildly pruritic lesions on the arms which resolved.   Within 1-2 weeks after the second vaccine the same lesions on arms, chest, legs appeared in abundance.  More importantly she developed nausea, anorexia, fatigue, weight loss and extensive bruising on the entirety of both legs.  Liver issues were suspected and full set of blood work revealed ELEVATED TRANSAMINASES to the mid 300s.  All other labs including CBC, hepatitis titers, CMV, ANA were all negative as was an ultrasound.  Patient stopped the supplements and slowly resolved over the next month
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ultrasound liver normal, Weight decreased
Clinical narrative: Within one week of receiving the first Pfizer vaccine patient had about 10 papular, red, mildly pruritic lesions on the arms which resolved.   Within 1-2 weeks after the second vaccine the same lesions on arms, chest, legs appeared in abundance.  More importantly she developed nausea, anorexia, fatigue, weight loss and extensive bruising on the entirety of both legs.  Liver issues were suspected and full set of blood work revealed ELEVATED TRANSAMINASES to the mid 300s.  All other labs including CBC, hepatitis titers, CMV, ANA were all negative as was an ultrasound.  Patient stopped the supplements and slowly resolved over the next month
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 2nd vaccine; breakthrough case
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received Pfizer COVID-19 vaccine which was beyond the manufacturer recommended use time of 31 days at the refrigerated temperature. Organization has been in direct contact with the vaccine manufacturer regarding this issue. Pfizer has data to support the stability of the vaccine up to 45 days at refrigerated temperatures. The vaccine given was within this range which is supported by the above data. No known adverse outcomes.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered BUD.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: EXTREME CHILLS, HEADACHE
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 3rd vaccine; breakthrough case
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging normal, Tinnitus
Clinical narrative: 3 days later after the vaccine, all of the sudden I got a call and I normally answer with my left hand on my left ear and I heard a lot of static so I moved it to the right ear and again, I heard static and that is when it hit me that it wasn't the phone. It was my ear. I did not have any pain or nothing, just static on both ears. I cannot hear people over the phone. Also, when I have my family talking or even the TV I hear like an echo and static, It's a weird thing. On 12/19/2021 I went to see Doctor and I was given steroid, 3 weeks after that I was given a MRI and he couldn't find anything, No tumor no nothing. Everything looked good.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea
Clinical narrative: About 10ish in the morning I started having a headache, when I started getting ready for work I felt very light headed and nauseous to a point where I had to sit down. I ended up staying home to rest the rest of the day taking ibuprofen and just resting. I was feeling better the next morning.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: I did not notice that the vaccine had been mixed 01/27/2022 so it was expired by 24 hours.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient is a refugee and had incorrect date of birth charted - was presumed to be 18 year old and received adult dose of Pfizer vaccine. When she returned for her second dose on 2/5/2022, she had documentation of her birthday being (privacy). She received the adult Pfizer vaccine at 11 years old.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 2nd vaccine; breakthrough case
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Fatigue, Nausea
Clinical narrative: Improving abdominal pain, fatigue, and nausea
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Dyspnoea, Electrocardiogram normal, Hyperhidrosis
Clinical narrative: Patient received vaccine and 5 minutes later had severe chest pain on his left side that was rated a 10.  Was diaphoretic and dizzy.  Also short of breath.  Pain was a 3 after 5 minutes and then resolved.  Patient went to ER for evaluaiton
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin
Clinical narrative: Patient received vaccine and 5 minutes later had severe chest pain on his left side that was rated a 10.  Was diaphoretic and dizzy.  Also short of breath.  Pain was a 3 after 5 minutes and then resolved.  Patient went to ER for evaluaiton
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Renal pain, Urine analysis abnormal
Clinical narrative: Both kidneys felt like they weighed 10+ pounds each. I experienced dull pain which was constant. It was not an issue if I sat or laid down however when I would stand up it would appear.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, Blood bicarbonate increased, Blood creatinine increased, Body temperature increased
Clinical narrative: This is a 73-year-old female with past medical history of DVT/PE fibromyalgia, RA, CAD status post stents, CKD who presented to the ED for complaint of cough. Patient reports she noted the cough started 2 days ago and just feeling weak. In the ED, patient was noted for temperature 100.8, 95% on room air which had decreased to 91% and was placed on oxygen. Lab work notable for bicarb 32 creatinine 1.41 procalcitonin 0.11 INR 1.8. Urinalysis notable for WBC 21-50. Patient tested positive for COVID-19. Chest x-ray unremarkable. Venous Doppler negative for DVT. In the ED, patient was given Macrobid, 1 L IV fluids and Decadron. Due to above concern with patient's symptoms and oxygen status, patient be admitted for further evaluation treatment. DEATH SUMMARY: Patient admitted for dyspnea respiratory distress, diagnosed with COVID pneumonitis, treated with BIPAP for acute respiratory failure.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchogram, COVID-19, COVID-19 pneumonia, Chest X-ray normal, Cough
Clinical narrative: This is a 73-year-old female with past medical history of DVT/PE fibromyalgia, RA, CAD status post stents, CKD who presented to the ED for complaint of cough. Patient reports she noted the cough started 2 days ago and just feeling weak. In the ED, patient was noted for temperature 100.8, 95% on room air which had decreased to 91% and was placed on oxygen. Lab work notable for bicarb 32 creatinine 1.41 procalcitonin 0.11 INR 1.8. Urinalysis notable for WBC 21-50. Patient tested positive for COVID-19. Chest x-ray unremarkable. Venous Doppler negative for DVT. In the ED, patient was given Macrobid, 1 L IV fluids and Decadron. Due to above concern with patient's symptoms and oxygen status, patient be admitted for further evaluation treatment. DEATH SUMMARY: Patient admitted for dyspnea respiratory distress, diagnosed with COVID pneumonitis, treated with BIPAP for acute respiratory failure.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Dyspnoea, International normalised ratio increased, Oxygen saturation decreased, Pneumonia
Clinical narrative: This is a 73-year-old female with past medical history of DVT/PE fibromyalgia, RA, CAD status post stents, CKD who presented to the ED for complaint of cough. Patient reports she noted the cough started 2 days ago and just feeling weak. In the ED, patient was noted for temperature 100.8, 95% on room air which had decreased to 91% and was placed on oxygen. Lab work notable for bicarb 32 creatinine 1.41 procalcitonin 0.11 INR 1.8. Urinalysis notable for WBC 21-50. Patient tested positive for COVID-19. Chest x-ray unremarkable. Venous Doppler negative for DVT. In the ED, patient was given Macrobid, 1 L IV fluids and Decadron. Due to above concern with patient's symptoms and oxygen status, patient be admitted for further evaluation treatment. DEATH SUMMARY: Patient admitted for dyspnea respiratory distress, diagnosed with COVID pneumonitis, treated with BIPAP for acute respiratory failure.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Procalcitonin, Respiratory distress, SARS-CoV-2 test positive, Ultrasound Doppler
Clinical narrative: This is a 73-year-old female with past medical history of DVT/PE fibromyalgia, RA, CAD status post stents, CKD who presented to the ED for complaint of cough. Patient reports she noted the cough started 2 days ago and just feeling weak. In the ED, patient was noted for temperature 100.8, 95% on room air which had decreased to 91% and was placed on oxygen. Lab work notable for bicarb 32 creatinine 1.41 procalcitonin 0.11 INR 1.8. Urinalysis notable for WBC 21-50. Patient tested positive for COVID-19. Chest x-ray unremarkable. Venous Doppler negative for DVT. In the ED, patient was given Macrobid, 1 L IV fluids and Decadron. Due to above concern with patient's symptoms and oxygen status, patient be admitted for further evaluation treatment. DEATH SUMMARY: Patient admitted for dyspnea respiratory distress, diagnosed with COVID pneumonitis, treated with BIPAP for acute respiratory failure.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis, White blood cells urine positive
Clinical narrative: This is a 73-year-old female with past medical history of DVT/PE fibromyalgia, RA, CAD status post stents, CKD who presented to the ED for complaint of cough. Patient reports she noted the cough started 2 days ago and just feeling weak. In the ED, patient was noted for temperature 100.8, 95% on room air which had decreased to 91% and was placed on oxygen. Lab work notable for bicarb 32 creatinine 1.41 procalcitonin 0.11 INR 1.8. Urinalysis notable for WBC 21-50. Patient tested positive for COVID-19. Chest x-ray unremarkable. Venous Doppler negative for DVT. In the ED, patient was given Macrobid, 1 L IV fluids and Decadron. Due to above concern with patient's symptoms and oxygen status, patient be admitted for further evaluation treatment. DEATH SUMMARY: Patient admitted for dyspnea respiratory distress, diagnosed with COVID pneumonitis, treated with BIPAP for acute respiratory failure.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Arthralgia, Back pain, COVID-19, Chest pain
Clinical narrative: On 01/10/2022 - SOB and fatigue. and continued on the 01/11/2022. On 01/12/2022 severe SOB, sever fatigue, sharp chest pains.  01/13/2022- leg pain and swelling, added to what was already existing, shoulder pain and back pain and that kind of continued. On 01/24/2022- I was sent to the ER,  by my doctor. I was admitted immediately and I had deep Vein thrombosis, blood clot on my right leg and pulmonary embolism in the lungs. 4 days of heparin through IV in the hospital from 01/24 - 01/27/2022, I was in the hospital.  I would say unknown . I am under going current treatment for 6 months. I have to go every week to get images done.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Deep vein thrombosis, Dyspnoea, Echocardiogram, Fatigue
Clinical narrative: On 01/10/2022 - SOB and fatigue. and continued on the 01/11/2022. On 01/12/2022 severe SOB, sever fatigue, sharp chest pains.  01/13/2022- leg pain and swelling, added to what was already existing, shoulder pain and back pain and that kind of continued. On 01/24/2022- I was sent to the ER,  by my doctor. I was admitted immediately and I had deep Vein thrombosis, blood clot on my right leg and pulmonary embolism in the lungs. 4 days of heparin through IV in the hospital from 01/24 - 01/27/2022, I was in the hospital.  I would say unknown . I am under going current treatment for 6 months. I have to go every week to get images done.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Imaging procedure, Pain in extremity, Peripheral swelling, Pulmonary embolism, SARS-CoV-2 test positive
Clinical narrative: On 01/10/2022 - SOB and fatigue. and continued on the 01/11/2022. On 01/12/2022 severe SOB, sever fatigue, sharp chest pains.  01/13/2022- leg pain and swelling, added to what was already existing, shoulder pain and back pain and that kind of continued. On 01/24/2022- I was sent to the ER,  by my doctor. I was admitted immediately and I had deep Vein thrombosis, blood clot on my right leg and pulmonary embolism in the lungs. 4 days of heparin through IV in the hospital from 01/24 - 01/27/2022, I was in the hospital.  I would say unknown . I am under going current treatment for 6 months. I have to go every week to get images done.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea
Clinical narrative: Cough and shortness of breath.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein, Chest X-ray, Electrocardiogram, Pericarditis
Clinical narrative: Pericarditis
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lethargy, Mobility decreased
Clinical narrative: From what I recollect, I was super tired, lethargic and unable to get out of bed for a couple of days. I did not seek any medical help, I just rested.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive for COVID-19.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Myalgia, Pyrexia
Clinical narrative: Chills, fever, cough and myalgias.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Skin warm
Clinical narrative: My left arm is still hurting now, hot to the touch as I write this email. It has been hurting ever since I took that shot in my left arm. I went back for my second shot it went fine, took the shot in my right no problem, but something is definitely wrong with my left arm.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: 10:30AM I started hiking and half way through had heart palpitations.  Eventually it became harder and pounding and continued for 45 minutes.  Was told by oncologist that it could be SBT.  It happened again on 1/26/22.  As a result, I went to see a cardiologist.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Feeling abnormal, Menstruation irregular, Panic attack
Clinical narrative: Not sure if it's related to the Vx. Started having an irregular period in the month of January, 3 months after vx. Had a panic attack about the same time as the irregular menstrual cycle. Started having brain fog 11/15/2021 thru 12/10/2021.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest discomfort, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: chest tightness, shortness of breath
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered BUD.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: patient described pain in the deltoid/shoulder in which she received her vaccination beginning 3 days post vaccination. The pain has remained.
Age: 98.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Agitation, Asthenia, Blood creatinine increased, Blood electrolytes normal
Clinical narrative: PROVIDER PROGRESS NOTE 2/07/2022 99 y/o F with HTN, history of complete heart block s/p pacemaker placement, restless leg syndrome, history of SBO, sigmoid perforation along with other issues came to hospital with complaints of gradually worsening weakness, fatigue and difficulty ambulation, found to be positive for COVID-19 pneumonia. Hospitalized for further evaluation of weakness.   # COVID-19 infection Tested positive on 1/27 She was hypoxic for a very short time at presentation and was given Decadron until 1/31 Currently O2 sats are stable on room air, remains off Decadron since 1/31.  Remains afebrile with normal procalcitonin. D/w infection control -please DC full barrier precautions since > 10 days   # Weakness/deconditioning:  has been getting weak for the last few days.   UCX wih pansensitive E. coli.  Also turned out to be positive for COVID-19 infection.  These both could be contributing to her weakness.   PT recommends TCU   # Acute cystitis/urethritis: UA was slightly abnormal.  She is asymptomatic.  However cultures are growing E. Coli. Rocephin x3 days from 1/28-1/30 finished. UCX showed pansensitive E. Coli.   # Dehydration: # Mild AKI with ATN: Creatinine slightly high at 1.12, BUN 37.  Electrolytes are otherwise stable.  Previous creatinine was in within normal limit.  With oral intake creatinine improved to 0.94.  Continue to encourage oral intake.  BUN continues to be on the higher side.      # Acute delirium, likely component of metabolic encephalopathy in the setting of acute illness Some evening/nighttime agitation noted.  Seems to be resting well this morning.   Avoid Benadryl, benzos cont melatonin and Zyprexa as needed.    # History of high-grade heart block, s/p pacemaker placement: No intervention needed now.   # Hypertension: Blood pressures stable.  She is on as needed hydralazine.   # DVT prophylaxis: HSQ   # Code status: DNR   # family communication: D/w daughter and SIL on 2/7   # Disposition: TCU    # Discharge criteria: Awaiting bed placement.  No further inpatient work-up. D/w SW
Age: 98.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urea increased, COVID-19, COVID-19 pneumonia, Culture urine positive, Cystitis
Clinical narrative: PROVIDER PROGRESS NOTE 2/07/2022 99 y/o F with HTN, history of complete heart block s/p pacemaker placement, restless leg syndrome, history of SBO, sigmoid perforation along with other issues came to hospital with complaints of gradually worsening weakness, fatigue and difficulty ambulation, found to be positive for COVID-19 pneumonia. Hospitalized for further evaluation of weakness.   # COVID-19 infection Tested positive on 1/27 She was hypoxic for a very short time at presentation and was given Decadron until 1/31 Currently O2 sats are stable on room air, remains off Decadron since 1/31.  Remains afebrile with normal procalcitonin. D/w infection control -please DC full barrier precautions since > 10 days   # Weakness/deconditioning:  has been getting weak for the last few days.   UCX wih pansensitive E. coli.  Also turned out to be positive for COVID-19 infection.  These both could be contributing to her weakness.   PT recommends TCU   # Acute cystitis/urethritis: UA was slightly abnormal.  She is asymptomatic.  However cultures are growing E. Coli. Rocephin x3 days from 1/28-1/30 finished. UCX showed pansensitive E. Coli.   # Dehydration: # Mild AKI with ATN: Creatinine slightly high at 1.12, BUN 37.  Electrolytes are otherwise stable.  Previous creatinine was in within normal limit.  With oral intake creatinine improved to 0.94.  Continue to encourage oral intake.  BUN continues to be on the higher side.      # Acute delirium, likely component of metabolic encephalopathy in the setting of acute illness Some evening/nighttime agitation noted.  Seems to be resting well this morning.   Avoid Benadryl, benzos cont melatonin and Zyprexa as needed.    # History of high-grade heart block, s/p pacemaker placement: No intervention needed now.   # Hypertension: Blood pressures stable.  She is on as needed hydralazine.   # DVT prophylaxis: HSQ   # Code status: DNR   # family communication: D/w daughter and SIL on 2/7   # Disposition: TCU    # Discharge criteria: Awaiting bed placement.  No further inpatient work-up. D/w SW
Age: 98.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Delirium, Escherichia infection, Fatigue, Gait disturbance
Clinical narrative: PROVIDER PROGRESS NOTE 2/07/2022 99 y/o F with HTN, history of complete heart block s/p pacemaker placement, restless leg syndrome, history of SBO, sigmoid perforation along with other issues came to hospital with complaints of gradually worsening weakness, fatigue and difficulty ambulation, found to be positive for COVID-19 pneumonia. Hospitalized for further evaluation of weakness.   # COVID-19 infection Tested positive on 1/27 She was hypoxic for a very short time at presentation and was given Decadron until 1/31 Currently O2 sats are stable on room air, remains off Decadron since 1/31.  Remains afebrile with normal procalcitonin. D/w infection control -please DC full barrier precautions since > 10 days   # Weakness/deconditioning:  has been getting weak for the last few days.   UCX wih pansensitive E. coli.  Also turned out to be positive for COVID-19 infection.  These both could be contributing to her weakness.   PT recommends TCU   # Acute cystitis/urethritis: UA was slightly abnormal.  She is asymptomatic.  However cultures are growing E. Coli. Rocephin x3 days from 1/28-1/30 finished. UCX showed pansensitive E. Coli.   # Dehydration: # Mild AKI with ATN: Creatinine slightly high at 1.12, BUN 37.  Electrolytes are otherwise stable.  Previous creatinine was in within normal limit.  With oral intake creatinine improved to 0.94.  Continue to encourage oral intake.  BUN continues to be on the higher side.      # Acute delirium, likely component of metabolic encephalopathy in the setting of acute illness Some evening/nighttime agitation noted.  Seems to be resting well this morning.   Avoid Benadryl, benzos cont melatonin and Zyprexa as needed.    # History of high-grade heart block, s/p pacemaker placement: No intervention needed now.   # Hypertension: Blood pressures stable.  She is on as needed hydralazine.   # DVT prophylaxis: HSQ   # Code status: DNR   # family communication: D/w daughter and SIL on 2/7   # Disposition: TCU    # Discharge criteria: Awaiting bed placement.  No further inpatient work-up. D/w SW
Age: 98.0
Sex: F
Vaccine: COVID19
Symptoms: Hypophagia, Hypoxia, Metabolic encephalopathy, Physical deconditioning, Procalcitonin
Clinical narrative: PROVIDER PROGRESS NOTE 2/07/2022 99 y/o F with HTN, history of complete heart block s/p pacemaker placement, restless leg syndrome, history of SBO, sigmoid perforation along with other issues came to hospital with complaints of gradually worsening weakness, fatigue and difficulty ambulation, found to be positive for COVID-19 pneumonia. Hospitalized for further evaluation of weakness.   # COVID-19 infection Tested positive on 1/27 She was hypoxic for a very short time at presentation and was given Decadron until 1/31 Currently O2 sats are stable on room air, remains off Decadron since 1/31.  Remains afebrile with normal procalcitonin. D/w infection control -please DC full barrier precautions since > 10 days   # Weakness/deconditioning:  has been getting weak for the last few days.   UCX wih pansensitive E. coli.  Also turned out to be positive for COVID-19 infection.  These both could be contributing to her weakness.   PT recommends TCU   # Acute cystitis/urethritis: UA was slightly abnormal.  She is asymptomatic.  However cultures are growing E. Coli. Rocephin x3 days from 1/28-1/30 finished. UCX showed pansensitive E. Coli.   # Dehydration: # Mild AKI with ATN: Creatinine slightly high at 1.12, BUN 37.  Electrolytes are otherwise stable.  Previous creatinine was in within normal limit.  With oral intake creatinine improved to 0.94.  Continue to encourage oral intake.  BUN continues to be on the higher side.      # Acute delirium, likely component of metabolic encephalopathy in the setting of acute illness Some evening/nighttime agitation noted.  Seems to be resting well this morning.   Avoid Benadryl, benzos cont melatonin and Zyprexa as needed.    # History of high-grade heart block, s/p pacemaker placement: No intervention needed now.   # Hypertension: Blood pressures stable.  She is on as needed hydralazine.   # DVT prophylaxis: HSQ   # Code status: DNR   # family communication: D/w daughter and SIL on 2/7   # Disposition: TCU    # Discharge criteria: Awaiting bed placement.  No further inpatient work-up. D/w SW
Age: 98.0
Sex: F
Vaccine: COVID19
Symptoms: Renal tubular necrosis, SARS-CoV-2 test positive, Urethritis, Urine analysis abnormal
Clinical narrative: PROVIDER PROGRESS NOTE 2/07/2022 99 y/o F with HTN, history of complete heart block s/p pacemaker placement, restless leg syndrome, history of SBO, sigmoid perforation along with other issues came to hospital with complaints of gradually worsening weakness, fatigue and difficulty ambulation, found to be positive for COVID-19 pneumonia. Hospitalized for further evaluation of weakness.   # COVID-19 infection Tested positive on 1/27 She was hypoxic for a very short time at presentation and was given Decadron until 1/31 Currently O2 sats are stable on room air, remains off Decadron since 1/31.  Remains afebrile with normal procalcitonin. D/w infection control -please DC full barrier precautions since > 10 days   # Weakness/deconditioning:  has been getting weak for the last few days.   UCX wih pansensitive E. coli.  Also turned out to be positive for COVID-19 infection.  These both could be contributing to her weakness.   PT recommends TCU   # Acute cystitis/urethritis: UA was slightly abnormal.  She is asymptomatic.  However cultures are growing E. Coli. Rocephin x3 days from 1/28-1/30 finished. UCX showed pansensitive E. Coli.   # Dehydration: # Mild AKI with ATN: Creatinine slightly high at 1.12, BUN 37.  Electrolytes are otherwise stable.  Previous creatinine was in within normal limit.  With oral intake creatinine improved to 0.94.  Continue to encourage oral intake.  BUN continues to be on the higher side.      # Acute delirium, likely component of metabolic encephalopathy in the setting of acute illness Some evening/nighttime agitation noted.  Seems to be resting well this morning.   Avoid Benadryl, benzos cont melatonin and Zyprexa as needed.    # History of high-grade heart block, s/p pacemaker placement: No intervention needed now.   # Hypertension: Blood pressures stable.  She is on as needed hydralazine.   # DVT prophylaxis: HSQ   # Code status: DNR   # family communication: D/w daughter and SIL on 2/7   # Disposition: TCU    # Discharge criteria: Awaiting bed placement.  No further inpatient work-up. D/w SW
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest pain, Headache, SARS-CoV-2 test positive
Clinical narrative: chest pain, headache
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 2nd dose; breakthrough case
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Pain in extremity, Pyrexia
Clinical narrative: Sore arm, fever, chills
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue, Underdose
Clinical narrative: Pfizer Vaccine was diluted with Sodium Chloride 0.9%, nurse was unaware that Grey Cap Pfizer Vaccine for 12 and up did not need to be diluted. Vaccine was drawn up as 0.3ml and given to the patient in the left deltoid. We are reporting this because we are unsure if patient needs to be given another dose since diluation was drawn up and injected into the vial.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative
Clinical narrative: She had a low grade fever of 100.6 at max. She also had congestion.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 3rd dose; breakthrough case
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was given Moderna for his first COVID vaccine on 12/28/21. Moderna given for 2nd dose on 1/25/2022. No complications noted.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 2nd vaccine; breakthrough case.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered Beyond Use Date.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Heavy menstrual bleeding
Clinical narrative: Prolonged (2 weeks) light menstruation in post/peri menopausal woman that stated <1  month after Moderna booster.   Unanticipated menstruation in last-minute cancellation of annual ob/gyn appt that had been scheduled >1 year in advance.    As a relatively healthy adult <50 yo, I would not have gotten boosted if not but for public health nonresponse and/or misinformation in light of Omicron, including CDC erroneously reporting ?73%? Omicron for sequenced covid samples and ableist public authorities not caring about preventable deaths of people who ?were unwell anyway.?     Post-vaccination anxiety due to credible experts reporting emerging evidence of original antigenic sin, in addn to potential called out by credible experts in late November 2021, but no public/transparent program discussion of actual risks/benefits of booster recommendation (or of Pfizer boosters for younger adolescents, despite FDA prolonged reticence re Moderna booster for younger adolescents).
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 3rd vaccine, breakthrough case.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Dysarthria, Dyspnoea, Feeling abnormal, Hypoaesthesia, Muscular weakness
Clinical narrative: Numbness, shortness breath, weakness in the extremities, fuzzy head, slurring words still having symptoms
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Dyspnoea, Haemoglobin decreased
Clinical narrative: Patient states she received the Pfizer two dose series plus one booster: 4/9/21, 4/27/21, 11/12/21.   Any information requests left blank were done so intentionally due to inability of information procurement.   Patient presents to ED with extremely low hemoglobin, cough, subjective fevers, SOA.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient states she received the Pfizer two dose series plus one booster: 4/9/21, 4/27/21, 11/12/21.   Any information requests left blank were done so intentionally due to inability of information procurement.   Patient presents to ED with extremely low hemoglobin, cough, subjective fevers, SOA.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 YR OLD TEEN RECEIVED 2 DOSES OF MODERNA COVID VACCINES
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Patient received the pediatric Pfizer (PEDS) Covid-19 vaccine and pediatric dose (0.2 mL) instead of adult Pfizer vaccine and dose. RN administered vaccination before entering documentation into patient record and, thus, did not catch the error.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive
Clinical narrative: Asymptomatic Positive
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, Catheterisation cardiac normal, Chest pain, Dyspnoea, Dyspnoea exertional
Clinical narrative: He developed mild chest pain and SOB 1 day following vaccination. His symptoms progressed over 48 hours. He developed more severe chest pain. He had neck pain with radiation down his left arm, and dyspnea on exertion. Chest pain became severe. He presented to hospital and diagnosed with acute myopericarditis.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram normal, Electrocardiogram ST segment elevation, Myocarditis, Neck pain, Pain
Clinical narrative: He developed mild chest pain and SOB 1 day following vaccination. His symptoms progressed over 48 hours. He developed more severe chest pain. He had neck pain with radiation down his left arm, and dyspnea on exertion. Chest pain became severe. He presented to hospital and diagnosed with acute myopericarditis.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Troponin
Clinical narrative: He developed mild chest pain and SOB 1 day following vaccination. His symptoms progressed over 48 hours. He developed more severe chest pain. He had neck pain with radiation down his left arm, and dyspnea on exertion. Chest pain became severe. He presented to hospital and diagnosed with acute myopericarditis.
Age: 16.0
Sex: F
Vaccine: VARCEL
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient was given a third dose of vaccine.  There were no adverse reactions.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Diarrhoea, Headache, Injection site swelling
Clinical narrative: Fever, Chills, Body Aches, Headaches, Upset Stomach, Diarrhea, and Injection Site Swelling.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Fever, Chills, Body Aches, Headaches, Upset Stomach, Diarrhea, and Injection Site Swelling.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive for COVID-19.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered BUD